Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 8/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 8/20 | 0.39 |
| ▸ | BRAF | P15056 | 4/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 7/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1846102 | 0.95 | ERN1 (0.40) | ERN1PIK3CABRAFNR1I2MTOR | |
| SCHEMBL1847704 | 0.88 | SCN9A (0.42) | ERN1PIK3CABRAFNR1I2MTOR | |
| SCHEMBL1847135 | 0.86 | ERN1 (0.39) | ERN1PIK3CABRAFNR1I2MTOR | |
| SCHEMBL1849642 | 0.85 | PIK3CA (0.40) | ERN1PIK3CABRAFMTOR | |
| SCHEMBL574872 | 0.85 | BRAF (0.47) | ERN1PIK3CABRAFNR1I2MTOR | |
| SCHEMBL1851673 | 0.84 | PIK3CA (0.40) | ERN1PIK3CABRAFMTOR | |
| SCHEMBL1845246 | 0.83 | MAPK13 (0.48) | ERN1PIK3CABRAFNR1I2MTOR | |
| SCHEMBL1847457 | 0.83 | BRD4 (0.42) | PIK3CABRAFMTOR | |
| SCHEMBL1851772 | 0.82 | PIK3CA (0.42) | ERN1PIK3CAMTOR | |
| SCHEMBL1847759 | 0.82 | BRAF (0.40) | BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2324008-A1 | 3,4-DIARYLPYRAZOLES AS PROTEIN KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010010154-A1 | 3,4-DIARYLPYRAZOLES AS PROTEIN KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2010-01-28 | — | — | WO | disclosed |